The Saudi Food and Drug Authority (SFDA) has published a comprehensive report titled “Journey of Change and Health Transformations”, detailing its key achievements in promoting healthier dietary patterns in Saudi Arabia. The report highlighted the Authority’s ongoing commitment to enhancing public health and advancing the Quality of Life Program under Saudi Vision 2030.

To leverage modern technologies in its regulatory operations, the CEO of the Saudi Food and Drug Authority (SFDA), H.E. Dr. Hisham S. Aljadhey, launched Automation and Use of Artificial Intelligence for Food Control". The launch took place during the fourth edition of the Digital Government Forum 2025, held in Riyadh from November 5–6.

The Saudi Food and Drug Authority (SFDA) organized its Regulatory Research Day 2025 event on Monday at its headquarters in Riyadh. The event was attended by the CEO of the SFDA, H.E. Dr. Hisham S. Aljadhey, along with a number of researchers, officials, and representatives from scientific institutions.

The CEO of the Saudi Food and Drug Authority (SFDA), H.E. Dr. Hisham S. Aljadhey, launched the National Network for Drugs and Medical Products Safety During Pregnancy and Breastfeeding on the sidelines of the SFDA's participation in the Global Health Exhibition. The Exhibition was held in Riyadh from October 27–30, with the participation of more than 2,000 entities from around the world.

The Saudi Food and Drug Authority (SFDA) yesterday, Wednesday, signed a Memorandum of Cooperation (MOC) with the Saudi Public Health Authority (Weqaya) to set an institutional framework that governs the exchange of expertise and collaboration areas between the two parties. The signing took place on the sidelines of the Global Health Exhibition 2025, which is currently being held at the Riyadh Exhibition and Convention Center under the theme “Invest in Health,” and is set to continue until October 30.

The Saudi Food and Drug Authority (SFDA) organized two specialized workshops on its Digital Health Platform as part of its participation in the Global Health Exhibition 2025, held in Riyadh under the theme “Invest in Health.” The workshops aimed to highlight leading regulatory practices in clinical trials for medical devices and in digital and emerging health technologies.

The CEO of the Saudi Food and Drug Authority (SFDA), H.E. Dr. Hisham S. Aljadhey, launched an AI-powered model for predicting drug shortages in the Kingdom of Saudi Arabia. The launch took place during the Global Health Exhibition, held from October 27 to 30. It highlights the SFDA's commitment to enhance drug monitoring and proactively address any potential shortages.

The CEO of the Saudi Food and Drug Authority (SFDA), H.E. Dr. Hisham S. Aljadhey, launched the Electronic Integration of Medications Risk Minimization Measures with a number of collaborating hospitals. The launch took place on the sidelines of the Global Health Exhibition, held from October 27 to 30 at the Riyadh International Convention and Exhibition Center in Malham, under the theme "Invest in Health."

The CEO of the Saudi Food and Drug Authority (SFDA), H.E. Dr. Hisham S. Aljadhey, reviewed the Kingdom of Saudi Arabia’s experience in supporting drug availability for patients and beneficiaries. He highlighted the role of an integrated digital infrastructure and the reliance on artificial intelligence technologies to ensure the success of the initiative. His remarks were delivered today, Tuesday, during his virtual participation at the parallel program at the National Defense College in the Sultanate of Oman, entitled, "Health Security: Reality and Aspiration."

The Saudi Food and Drug Authority (SFDA) and King Saud bin Abdulaziz University for Health Sciences (KSAU) have signed a Memorandum of Cooperation (MOC) to establish a strategic partnership aimed at leveraging shared capabilities and expertise.

The signing ceremony took place on Tuesday, on the sidelines of the Global Health Exhibition 2025, currently being held at the Riyadh International Convention and Exhibition Center under the theme "Invest in Health," running until October 30.